scholarly article | Q13442814 |
P2093 | author name string | G. Schmitz | |
G. Rogler | |||
K. J. Lackner | |||
P2860 | cites work | The pathogenesis of atherosclerosis: a perspective for the 1990s | Q29547827 |
A Detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis | Q34249812 | ||
Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian Coronary Atherosclerosis Intervention Trial. | Q51596506 | ||
Requirement for mevalonate in cycling cells: quantitative and temporal aspects | Q67931587 | ||
Relationship between mevalonate pathway and arterial myocyte proliferation: in vitro studies with inhibitors of HMG-CoA reductase | Q72547620 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | statin | Q954845 |
P304 | page(s) | 114A-116A | |
P577 | publication date | 1995-07-01 | |
1995-07-13 | |||
P1433 | published in | American Journal of Cardiology | Q2208417 |
P1476 | title | Effects of fluvastatin on growth of porcine and human vascular smooth muscle cells in vitro | |
Effects of flwastatin on growth of porcine and human vascular smooth muscle cells in vitro | |||
P478 | volume | 76 |
Q35756752 | Association of dyslipidemia and effects of statins on nonmacrovascular diseases |
Q33843636 | C-reactive protein, inflammation, and coronary risk |
Q79299389 | C-reactive protein, inflammation, and coronary risk |
Q41141172 | Differentiated properties and proliferation of arterial smooth muscle cells in culture. |
Q36577189 | Drug insight: Immunomodulatory effects of statins--potential benefits for renal patients? |
Q73176738 | HMG CoA reductase inhibitors are related to improved systemic endothelial function in coronary artery disease |
Q44620895 | Inhibition of Hydroxymethylglutaryl-Coenzyme A Reductase Reduces Th1 Development and Promotes Th2 Development |
Q50522879 | Inhibitory effect of photooxidation on intimal and medial thickening of saphenous vein. |
Q22241432 | Role of HMG-CoA Reductase Inhibitors in Neurological Disorders |
Q77220461 | Simvastatin decreases aldehyde production derived from lipoprotein oxidation |
Q41169571 | Statins do more than just lower cholesterol |
Q46506824 | The HMG-CoA reductase inhibitor rosuvastatin and the angiotensin receptor antagonist candesartan attenuate atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes via effects on advanced glycation, oxidative stress and inflammation |
Q33818141 | The evolving role of statins in the management of atherosclerosis |
Search more.